Early treatments for COVID-19
The 7,568 treatments below have been reported as potentially beneficial for COVID-19. We currently review studies for:
acetaminophen
adintrevimab
alkalinization
andrographolide
antiandrogens
aspirin
azvudine
bamlanivimab/etesevimab
bebtelovimab
bemnifosbuvir
bromhexine
budesonide
cannabidiol
casirivimab/imdevimab
cetylpyridinium chloride
chlorhexidine
colchicine
convalescent plasma
curcumin
deuremidevir
diet
ensitrelvir
ensovibep
exercise
famotidine
favipiravir
fluvoxamine
HCQ
HH-120
hydrogen peroxide
ibuprofen
indomethacin
iota-carrageenan
ivermectin
lactoferrin
lufotrelvir
melatonin
metformin
molnupiravir
N-acetylcysteine
nigella sativa
nitazoxanide
nitric oxide
paxlovid
peginterferon lambda
phthalocyanine
povidone-iodine
probiotics
propolis
proxalutamide
quercetin
regdanvimab
remdesivir
selenium
sleep
sotrovimab
spironolactone
sunlight
thermotherapy
tixagevimab/cilgavimab
ursodeoxycholic acid
vitamin A
vitamin B12
vitamin B9
vitamin C
vitamin D
vitamin K
xiannuoxin
zinc
The following papers report potential benefits of 7,499
other treatments. We have not reviewed these studies.
Sort by number of studies
Sort alphabetically
Submit updates
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.